Work

JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials

Year: 2007
Type: review
Source: Leukemia
Author: A Pardanani
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2045542032
FWCI: 6.436
Cites: 101
Cited by: 217
Related to: 10